November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreOctober 22, 2025
Market insights predict the global circadian rhythm sleep disorder industry will increase from USD 2.33 billion in 2024 to USD 4.38 billion by 2034, achieving a CAGR of 6.56%. The circadian rhythm sleep disorder market is growing due to the growing focus on occupational health and efforts taken by employers. North America captured the largest reven...
October 22, 2025
The rising prevalence of Type 2 diabetes has driven the growth of the market in the near future. North America led the global market owing to its advanced healthcare infrastructure in the region....
October 20, 2025
Market insights predict, the U.S. CAR T-cell therapies industry is expected to grow from USD 2.71 billion in 2025 to USD 42.61 billion by 2035, driven by a CAGR of 30.40%. The U.S. CAR T-Cell Therapies Market is growing, as this therapy has high efficacy against blood cancers, robust research and development, and government bodies are accelerating ...
October 20, 2025
According to market projections, the DNA damaging agents sector is expected to grow from USD 15.33 billion in 2024 to USD 46.31 billion by 2034, reflecting a CAGR of 11.67%. Ongoing developments in the cancer domain are impacting the global market expansion. North America led the market due to a rise in cancer cases....
October 17, 2025
According to market projections, the global generic drug CRO market, valued at USD 8.45 billion in 2024, is anticipated to reach USD 11.73 billion by 2034, growing at a CAGR of 3.36% over the next decade. The generic drug CRO market is growing due to increasing demand for affordable healthcare services and the expiration of patents on major medicin...
October 16, 2025
The placental stem cell therapy for neurological disorders market is projected to grow from USD 535.63 million in 2025 to USD 2366.97 million by 2034 at a CAGR of 18.14%. The report covers segmentation by cell type, application, therapy type, product & services, and end-user. North America led with 40% revenue in 2024, while Asia Pacific is the...
October 15, 2025
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susceptible to cancer, increasing the patient pool for anti-cancer drugs. North America led the global ma...
October 14, 2025
The global over-the-counter (OTC) analgesic market, valued at USD 30.61 billion in 2024, is anticipated to reach USD 44.02 billion by 2034, growing at a CAGR of 3.7% over the next decade. An over-the-counter (OTC) analgesic is a pain-relieving medicine you can buy without a prescription. It helps reduce pain, fever, or inflammation and includes com...
October 14, 2025
The inhaled therapy in respiratory disease market is valued at USD 11.98 billion in 2025 and expected to reach USD 16.22 billion by 2034 at 3.44% CAGR. Dominant segments include bronchodilators (28%), MDIs (35%), COPD (38%), retail pharmacies (60%), and inhaled biologics growing fastest. North America holds 42% share, Asia Pacific fastest-growing. ...
October 14, 2025
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for personalized medicines drive the global market. North America dominated due to the availability of st...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com